VANGUARD GROUP INC - KINIKSA PHARMACEUTICALS LTD ownership

KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 131 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q2 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2023$51,397,083
+18.2%
2,958,957
-4.2%
0.00%0.0%
Q2 2023$43,467,944
+23.9%
3,087,212
-5.3%
0.00%0.0%
Q1 2023$35,084,303
-27.4%
3,260,623
+1.0%
0.00%0.0%
Q4 2022$48,338,828
+22.3%
3,226,891
+4.8%
0.00%0.0%
Q3 2022$39,536,000
+39.3%
3,079,192
+5.2%
0.00%0.0%
Q2 2022$28,372,000
-5.1%
2,927,981
-2.6%
0.00%0.0%
Q1 2022$29,886,000
-12.2%
3,006,650
+4.0%
0.00%0.0%
Q4 2021$34,022,000
+12.2%
2,890,708
+8.6%
0.00%0.0%
Q3 2021$30,328,000
-18.3%
2,662,626
-0.1%
0.00%0.0%
Q2 2021$37,114,000
-28.5%
2,664,323
-4.9%
0.00%0.0%
Q1 2021$51,884,000
+15.8%
2,803,047
+10.5%
0.00%0.0%
Q4 2020$44,819,000
+23.3%
2,536,421
+6.9%
0.00%0.0%
Q3 2020$36,344,000
-16.8%
2,372,284
+38.3%
0.00%
-50.0%
Q2 2020$43,697,000
+135.1%
1,714,942
+42.9%
0.00%
+100.0%
Q1 2020$18,584,000
+39.9%
1,200,511
-0.1%
0.00%
Q4 2019$13,288,000
+33.9%
1,201,453
+3.0%
0.00%
Q3 2019$9,927,000
-41.0%
1,166,511
-6.2%
0.00%
-100.0%
Q2 2019$16,835,000
-25.2%
1,243,362
-0.2%
0.00%0.0%
Q1 2019$22,507,000
-11.8%
1,246,224
+37.2%
0.00%0.0%
Q4 2018$25,514,000
+80.0%
908,273
+63.4%
0.00%0.0%
Q3 2018$14,178,000
+444.9%
555,991
+270.7%
0.00%
Q2 2018$2,602,000150,0000.00%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q2 2023
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 2,474,561$42,983,1255.17%
Rubric Capital Management LP 3,077,449$53,455,2892.00%
Parkman Healthcare Partners LLC 509,810$8,855,4001.62%
TANG CAPITAL MANAGEMENT LLC 600,000$10,422,0001.47%
AlphaCentric Advisors LLC 110,000$1,910,7001.08%
Lion Point Capital, LP 130,691$2,270,1031.01%
RICE HALL JAMES & ASSOCIATES, LLC 650,366$11,296,8570.72%
ESSEX INVESTMENT MANAGEMENT CO LLC 185,853$3,228,2670.53%
ADVISORY RESEARCH INC 204,098$3,545,1820.49%
Jackson Creek Investment Advisors LLC 65,607$1,1400.48%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders